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1. Introduction 
Graft-versus-host reaction (GVHR) is a cellular immune reaction developed by 
transplanting mature T-lymphocytes to tissue incompatible recipients. As it has been 
stated by R.E. Billingham in a Harvey Lecture, there are three requirements for the 
development of GVHR: the graft must contain immunologically competent cells; the 
recipient must be incapable of rejecting the transplanted cells; the recipient must express 
tissue antigens that are not present in the donor (Billingham, 1966, as cited in  Sun et al., 
2007). There are several situations in which it’s possible: the introduction of incompatible 
lymphocytes to newborn or adult immunocompromised recipients or the transfer parental 
lymphocytes to F1 hybrids. A recipient with a normal immune system will usually reject 
cells from a foreign donor. 
At the present time there are described and characterized two forms of graft-versus-host 
reaction: acute and chronic. The mechanisms of acute and chronic GVHR are distinguished 
by participating of CD8+T-cells. If the CD8+T-cells are involved in the development of 
immune processes, a primary stimulating phase of reaction (activation of the donor cell by 
recipient alloantigens) is followed by a cytotoxic phase including a generation of effector 
cells – cytotoxic T lymphocytes (CTL), directed against recipient alloantigens, and the 
reaction ends with destruction of host tissues. In general, it can be called a normal 
physiological immune reaction "graft versus host" – accomplished immune response of 
mature donor cells against allogeneic recipient. From this viewpoint chronic GVHR is an 
incomplete ("defective") GVHR: the reaction does not lead to formation of CD8+T-effector 
cells and to a development of a cytotoxic phase, as it should be, but «freezes» at a primary 
stimulating stage and ends with lymphoproliferation. Such type of the reaction may be 
caused by different situations: removal or inactivation of some inoculum T cells 
subpopulations, the suppression of the reaction by pharmacological agents at early stages, 
or the lack of donor T cells stimulation through the absence of MHC class I incompatibility. 
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Acute GVHR leads to severe cytotoxic reaction of transplanted cells against host tissues.  It’s 
characterized by thymic involution, pronounced hypoplasia of the lympho-hemopoietic 
tissue, including aplastic anemia, immunodeficiency, hypogammaglobulinemia, and sepsis. 
Acute GVHR often ends with the death of the recipient. Chronic GVHR is characterized by a 
long incubation period and relatively low mortality. It’s manifested by lymphoid 
hyperplasia, hypergammaglobulinemia, autoantibody formation. Chronic GVHR is more 
diverse in the immune mechanisms and accordingly in the clinical manifestations: it may be 
observed the development of immunodeficiency, the formation of different variants of 
autoimmune pathologies, lymphoproliferative processes, skin lesions, disorders of intestines 
(enteritis, colitis) and other internal organs (Gleichmann et al., 1984; Via & Shearer, 1988; 
Mori et al., 1998; Chu & Gress, 2008). 
It has been shown that GVHR may be useful model for study various human disorders.  
In mouse models of GVHR a reaction may be directed to MHC class I, MHC class II, or 
both or to isolated multiple minor histocompatibility antigens (miHA) alone. In each case 
the reaction is dependent on either CD8+T cells, CD4+T cells, or both, depending on the 
strain combination of donor and recipient. When donor and recipient are distinguished by 
MHC I and II classes acute GVHR occurs, whereas in the case of only MHC class II 
differences chronic GVHR is formed. Initially acute GVHR was considered Th1-
dependent and chronic GVHR - Th2-dependent form of reaction (Krenger & Ferrara, 1996; 
Okamoto et al., 2000; Shustov et al., 2000; Kataoka et al., 2001). Now it has become evident 
that this is an oversimplification and a situation is much more complicated. Currently it 
has been shown involvement either Th1- and Th2-subpopulation in the development of 
acute and chronic GVHR, and thus there are many unresolved issues concerning of GVHR 
mechanisms and participating of different cytokines and cell subpopulations, particularly 
with regard to the chronic form of the reaction (Koreth & Antin, 2008; Reddy & Ferrara, 
2009). 
2. Experimental model of glomerulonephritis induced by chronic GVHR 
Graft-versus-host reaction leads to the development of immunopathological states (graft-
versus-host disease – GVHD), in some cases similar to human disease which are caused by 
immune abnormalities. Primarily it refers to autoimmune diseases. The transfer parental 
lymphocytes to F1 hybrids is particularly appealing for use as models of human diseases. In 
this case it does not require to expose recipients previously to irradiation or cytotoxic drugs 
suppressing its ability to graft reject. 
In semiallogeneic system C57Bl/6(C57Bl/6xDBA/2)F1 donor and recipient are differ in 
the MHC class I and II and an acute form of reaction develops in accordance with a general 
rule. However if cells of the second parental line DBA/2 use for transplantation (the 
semiallogeneic system DBA/2(C57Bl/6xDBA/2)F1) chronic GVHD develops despite 
differences between donor and recipient by MHC classes I and II and miHAs (Gleichmann 
et al., 1984; Reddy et al., 2008; Kim et al., 2010). The inability of DBA/2 mice lymphocytes to 
induce acute GVHD may be explained by different production of inflammatory cytokines 
such as IFN  TNF, IL-6, which play an important role in the activation of CTL, in mice 
with H2b and H2d haplotype (De Maeyer-Guignard et al., 1986; Raj et al., 1992). Moreover, it 
has been shown that the population of CD8+lymphocytes in DBA/2 mice is quantitatively 
and qualitatively defective. CD8+T-cells of DBA/2 mice generate a weak response to BDF1 
alloantigen in vitro and the frequency of CTL precursors in DBA/2 mice is many times less 
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than one in C57Bl/6 mice (Via et al., 1987; Tschetter et al., 2000). Thus induction of GVHR in 
transfer system DBA/2(C57Bl/6xDBA/2)F1 does not lead to an acute form as it should be 
due genetic donor-recipient differences but causes a chronic GVHD dependent on CD4+ 
donor cells (Gleichmann et al., 1984; Reddy et al., 2008). There are a polyclonal activation of 
B cells, an increase of a total IgG level, a formation of multiple autoantibodies including 
antibodies to DNA. Autoantibodies found in this GVHR are of the IgG class whereas 
antibodies binding to a variety of self antigens and found in the peripheral blood of normal 
individuals are of the IgM class (Rolink et al., 1987).  Chronic GVHD results in a 
development of autoimmune disorder similar  human systemic lupus erythematosis (SLE) 
and in a formation of lupus-like immune complex glomerulonephritis (Via & Shearer, 1988). 
2.1 Two variants of GVHD induced in transfer system DBA/2(C57Bl/6xDBA/2)F1 
Studying this model we have discovered that although the typical chronic GVHR develops 
in all recipients reaction can proceed in two different directions despite the genetic 
homogeneity of recipients - (C57Bl/6xDBA/2)F1 mice. The development of chronic GVHR 
is sustained by increased spleen cell number and polyclonal B-cell activation in the absence 
of thymus destruction (Kozlov et al., 2002). The absence of destruction of lymphoid tissue, in 
particular, atrophy of the thymus is a sharp-cut distinctive feature of chronic GVHD from its 
acute form. Chronic GVHD is not accompanied by marked disruptions of thymus tissue, 
infiltration of the thymus by donor T-cells, pronounced structural changes, signs of local 
inflammation and disorders of cell proliferation (Krenger et al., 2000).  
2.1.1 Development of chronic GVHR  
The formation of glomerulonephritis is going on for 6 – 12 weeks (Fig. 1). The  
autoimmune glomerulonephritis develops in 50-60% recipients (a lupus group), whereas 
marked disorders of kidney are absent in the rest ones (a nonlupus group) (Fig. 2).  
 
 
Fig. 1. Frequency of lupus-like nephritis in the course of chronic GVHD development 
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The availability of the autoimmune glomerulonephritis has been tested by the urine protein 
level that has been strictly correlated with the appearance of immune complex deposits in 
kidney and morphological manifestations of kidney disorders as it has been verified 
previously (Kolesnikova et al., 1991).  
The development of the reaction is accompanied by the increase of total IgG level and the 
appearance of autoantibodies to own tissues components (dsDNA, erythrocytes) in the 
peripheral blood (Fig. 3) (Kudaeva et al., 2005a). 
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Fig. 2. Formation of glomerulonephritis in the course of chronic GVHD development 
2.1.2 Kidney morphology  
The severity of the pathological process in the kidneys is evaluated by a 4-marks scale 
depending on the number of glomeruli involved in the pathological process and the extent 
of their damage (Yoshioka et al., 1989; Muracami et al., 1995). 
Morphological study has shown that animals without proteinuria (a nonlupus group) have 
slight pathomorphological changes in the form of proliferative mesangium in some glomeruli, 
expressed in increasing in the number of mesangial cells and in the size of the glomerular 
capillaries. A weak proliferation of mesangial cells combines with dust-like deposits of IgG in 
the glomeruli and small proteinosis  of tubular epithelium. It is observed small periglomerular 
lymphoid infiltrates. The kidney structure is saved. Tubules dystrophy is absent. 
Morphological characteristics of renal pathology correspond to 1 in nonlupus recipients. 
In the group of animals with proteinuria (a lupus group) it is observed gross changes in 
renal tissue. Changes in the glomeruli become diffuse and are expressed in increasing the 
number of mesangial cells with mesangial matrix deposition, diffuse wall thickening of 
www.intechopen.com
The Experimental Model of the Autoimmune  
Glomerulonephritis Induced by the Chronic Graft versus Host Reaction 
 
53 
capillary loops until the hyalinosis lesions. Glomeruli become "gripping" look. 
Periglomerular lymphoid infiltrates meet constantly. Proteinosis of convoluted tubule 
epithelium is expressed sharply. In some cases there is the phenomenon of glomerular 
sclerosis. Deposits of IgG in the glomeruli have linear and granular character. 
Morphological characteristics of renal pathology correspond to 3.5 in lupus recipients. At 6-7 
months of illness proteinuria attains a high level and coarse sclerotic changes dominate in 
kidney tissue: multiple sclerosis and hyalinosis of many glomeruli, proliferation of renal 
capsule epithelium with the formation of "crescent", expressed tubular atrophy with cystic 
enlargement of the lumen, lymphoid infiltration of the interstitium. It is found granular IgG 
deposits in sclerosal glomeruli; content of cystic tubules are positive stained for IgG also. 
Thus the induction of chronic GVHD in  genetically identical recipients leads to the 
development of autoimmune glomerulonephritis in the part of the recipients. 
 
 
* - p < 0.05 compared between control and experimental group; # - p < 0.05 between experimental 
groups 
Fig. 3. The level of antibodies to dsDNA in recipients in the course of chronic GVHD 
development 
2.1.3 The Th1/Th2 balance 
The further study has revealed that different Th1/Th2 ratio is the main distinction between 
nonlupus and lupus recipients. Existence of two Th-subpopulations producing different 
cytokine sets and exerting opposing influence upon basic links of immune response has 
been described among murine CD4+T-cells in 1986 and then among human T-lymphocytes 
(Mosmann et al., 1986; Del Prete et al., 1991). It has led to conception of immune 
polarization: Th1/Th2 balance is the basic parameter of regulation of immune processes 
(Mosmann & Sad, 1996; Allen & Maizels, 1997; O’Gor et al., 2003). The Th-cell fate decision 
depends on specific Th1 or Th2 factors of transcription that is determined by a set of 
external epigenetic factors (Glimcher & Murphy, 2000; Wilson & Makarb, 2002; Agnello et 
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al., 2003). Choosing of each Th-cell differential way is subjected to influence of abundant 
factors connecting immune reactions with the current condition of a whole organism. The 
GVHD is among the processes in which Th1/Th2 balance plays the pivotal role.  
Application of this paradigm for studying the regulation of immunity in both normal 
physiological conditions and immune pathological states has proved fruitful, and today is 
widely used in the study of processes such as bacterial and viral infections, allergic diseases, 
immune responses during carcinogenesis, autoimmune disorders, immune conflicts in 
pregnancy (Fresno et al., 1997; Kunzendorf et al., 1998; Chaouat et al., 2003; Wilczynski, 
2005). Not all the currently known experimental facts and clinical observations perfectly fit 
into this concept. There are many new data on the participation of other T-cell 
subpopulations in the regulation of immune processes (Th17, Treg, ThF, Th9) (Mosmann et 
al., 2009). However the application of this paradigm remains useful to solve contemporary 
problems of the immune regulation. 
The following points indicate that Th1- or Th2-subpopulation is predominant in nonlupus- or 
lupus-mice respectively (Vlasov et al., 2002; Kozlov et al., 2002; Kudaeva et al., 2005b). It is 
known that in mice Th1-dependent immune response is characterized by increased IgG2a 
subclass level, whereas activation of Th2-cells is accompanied by an increase of IgG1 one 
(Snapper & Paul, 1987; Morris et al., 1994). Ratio of Th1- and Th2-dependent IgG subclasses 
in peripheral blood of mice with GVHD shows a pronounced shift toward IgG2a (Th1-
dependent subclass) in nonlupus mice and toward IgG1 (Th2-dependent subclass) in the 
lupus mice. Differences emerge at the early stages of reaction (1 month) and amplify over 
time (6 months) (Fig. 4). 
 
 
# - p < 0.05 compared between nonlupus and lupus 
Fig. 4. IgG1/IgG2a ratio in the serum of mice with chronic GVHD 
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There are many observations about the intimate direct correlation between the concentration 
of IgE and the level of the key Th2-cell cytokine IL-4 (Doutrelepont et al., 1991; Umland et 
al., 1992; Ushiyama et al., 1995). Determination of the IgE concentration in peripheral blood 
of recipients has shown a high IgE level during the development of chronic GVHD and the 
formation of glomerulonephritis. IgE content sharply increases at the initial stages of 
reaction, then reduces but remains significantly higher than one of intact animals. IgE levels 
in lupus mice is considerably superior to one in nonlupus recipients at all stages of reaction 
(Tabl. 1) (Goiman et al., 2009). 
 
 Control Nonlupus Lupus 
10 days  
 
6.95 
(2.2 – 10.6) 
 
20.0* 
(8.4 – 30.2) 
24.9* 
(8.2 – 41.9) 
24 days 
132.5* 
(54.2 – 348.6) 
232.1* 
(63.0 – 396.2) 
3 months 
24.3* # 
(15.0 – 36.6) 
69.2* # 
(22.5 – 166.4) 
* - p < 0.05 compared between control and experimental group; # - p < 0.05 between experimental 
groups 
Table 1. The IgE content in peripheral blood of recipients in the course of GVHD 
development (M, (min-max), g/ml) 
2.2 Characteristics of recipients with glomerulonephritis 
2.2.1 The homeostatic proliferation 
Homeostatic proliferation is a compensatory repair of quantitative deficit of lymphocytes by 
triggering their proliferation at the periphery. Homeostatic proliferation decreases the 
variety of antigen recognizing receptors and leads to the appearance of an appreciable 
amount of autoreactive effector cells (Baccala & Theofilopoulos, 2005; Marleau & Sarvetnick, 
2005). Now homeostatic proliferation is regarded as a possible mechanism of the 
development of autoimmune disease (Khoruts & Fraser, 2005; Surth & Sprent, 2008).  
Acute GVHR is associated with a drop of lymphocyte count. Chronic GVHR is called 
immunostimulatory, because lymphoproliferative reaction is indicative of it (Via & Shearer, 
1988). However measure of lymphocyte counts in the recipient peripheral blood over the 
course of reaction has revealed its drastic decrease at the early stage of chronic GVHR in this 
model. This decrease persists throughout the first two weeks and then is replaced by 
lymphocytosis followed by normalization of lymphocyte count in the peripheral blood 
against the background of developing splenomegaly (Tkachev et al., 2006). Hence it has 
been studied the possible involvement of homeostatic proliferation in the development of 
autoimmune disease - glomerulonephritis in this  model (Goiman et al., 2010). 
An obligatory condition for homeostatic proliferation of naive and memory CD4+ T-cell is 
high concentration of IL-7 (Schluns et al., 2000; Boyman et al., 2008). It has been shown the 
significantly increased level of endogenous splenic IL-7 mRNA in irradiated recipients with 
acute GVHR (Gendelman et al., 2004). The content of IL-7 in the peripheral blood of 
recipients with chronic GVHR sharply increases during the early period (25.5 pg/ml) and 
remains high within 3 months after induction of GVHD  in lupus recipients (6.5 pg/ml) in 
comparison with control animals (lower the verge of method) and nonlupus recipients (lower 
the verge of method) (Goiman et al., 2010).  
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The key characteristic of homeostatic proliferation is taking T memory cell phenotype 
(CD4+CD45RBlow and CD8+CD45RBlow) by naïve T cells (CD4+CD45RBhigh and 
CD8+CD45RBhigh). Despite the increase in both CD4+ subpopulations (naïve and memory) its 
proportion is shifted towards memory cells in lupus recipients. The T-cell donor chimerism 
is just 2% in chronic GVHR in this model (Via & Shearer, 1988). Hence, the CD4+CD45RBlow 
and CD8+CD45RBlow cells in the spleens of lupus mice are mainly recipient cells. 
It can be assumed that lymphopenia at the early stages of chronic GVHR causes homeostatic 
proliferation of T lymphocytes in lupus recipients, which participates in the development of 
autoimmune pathology in this model.  
2.2.2 The immune response of recipients  
GVHR is accompanied by immunosuppression. The mechanism of immunodeficiency has 
been well studied in case of acute reaction: it’s a destruction of the recipient's immune 
system by donor immune cells. The mechanism of immunosuppression in the chronic form 
of GVHR remains unclear (Kimura & Gleichmann, 1987; Haridas & Kamat, 1997; Kataoka et 
al, 2001; Chu & Gress, 2008). 
In spite of the occurrence of two different variants of chronic GVHR in this model the 
suppression of primary immune response to T-dependent antigen is observed in all 
recipients (Fig. 5) (Kozlov et al., 2002; Kudaeva et al., 2010b). The decrease of the primary 
response is significantly heavier in nonlupus recipients.  
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*  #  
*  #  
*  #  
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* - p < 0.05 compared between control and experimental group; # - p < 0.05 between experimental 
groups 
Fig. 5. The level of primary humoral immune response in recipients with chronic GVHD 
An enhancement of the suppressive activity of regulatory T cells, a disruption of the 
antigen-presenting cells, an increase of specific Th-cells apoptosis are considered as a 
possible reasons. Experiments in vitro indicate the possible inability of B lymphocytes in 
chronic GVHR to respond to T-dependent antigen. The latter can be explained by the 
abundance of activating factors leading to the ultimate differentiation of the few antigen 
specific B-cell and thus excluding its proliferation (Kimura & Gleichmann, 1987). 
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The inhibition of humoral immune response may be due to hyperactivation of the B-
lymphocytes. Indeed, the development of chronic GVHD is accompanied by a marked 
polyclonal activation of B-lymphocytes, which is known to impede an adequate response to 
new stimulus (Reina-San-Martin et al., 2000; Spera et al., 2006; Montes et al., 2007; Marques 
et al., 2008).  
At the same time a decrease of the secondary immune response is less marked especially in 
the lupus recipients (Fig. 6). Perhaps, it indicates that a formation of immune memory is 
more rigidly processes, resistant to the action of various factors. Explanation of this 
discordance between the level of primary and secondary response under chronic GVHD 
requires further investigation. 
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Fig. 6. The level of the secondary humoral immune response in recipients with chronic 
GVHD (A – spleen; B – bone marrow) 
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The suppression of humoral immune response to T-dependent antigen is observed in all 
recipients (nonlupus and lupus) and by this means is not specific feature of autoimmune 
disorder in this model. 
2.2.3 Anemia 
Hematological abnormalities are common in systemic lupus erythematosus and may be 
manifested in anemia of different pathogenesis. In SLE many factors are produced which 
disturb the hematological balance both on the peripheral level and in the bone marrow. It is 
assumed that the autoantibodies produced in SLE are the main cause of autoimmune 
hemolytic anemia. However it should be considered that quantitative changes in the 
number of erythrocytes observed in this disease are also caused by chronic inflammatory 
condition, which impairs the endocrine function of the kidneys in erythropoietin production 
as the element of autoimmune disease.  
 
Parameters control lupus 
Hemoglobin, g/l 199.5  3.5 137.3  6.9 ** 
Hematocrit, per cent 49.2  0.4 39.7  1.4 ** 
Reticulocytes, pro mille 10.0  1.3 26.2  4.7 ** 
Mm, * - p < 0.05 and ** - p < 0.01 compared between control and experimental group 
Table 2. Hematological parameters of lupus mice 
It has been shown that acute GVHD (C57BL/6(C57BL/6xDBA/2)F1) reduces the 
peripheral blood cell counts, the number of bone marrow cells, and colony forming unit-
granulocyte macrophage (CFU-GM), whereas  the host hematopoiesis in chronic GVHD  
(DBA/2(C57BL/6xDBA/2)F1) is not affected within 2 weeks after the transfer of parental 
splenocytes (Mori et al., 1998). However study of the host hematopoiesis at late stages of 
GVHD has revealed the set of immune- and hemopoiesis disorders (Kozlov et al., 1995). 
The results presented in Table 2 show that lupus mice have a significant decrease of 
hemoglobin and hematocrit levels in comparison with intact animals. Marked 
reticulocytosis corresponds to the expression of anemic syndrome and gives evidence of a 
quite regenerative ability of the lupus bone marrow. To clarify the nature of anemia 
assessment of early and late erythropoietic progenitors has been studied. Data on the 
number of erythroid precursors in the myelogram and the number of erythroid burst 
forming units (BFU-E) and colony forming unit-granulocyte macrophage in bone marrow 
are shown in Table 3.  
 
Parameters control lupus 
Nucleated erythroid precursors,  
per cent 
28.3  1.2 37.6  2.9 * 
BFU-E per 105 bone marrow cells 7.8  0.9 21.3  1.8 ** 
CFU- GM per 5x104 bone  
marrow cells 
8.7  0.7 (10) 4.7  0.5* 
M  m,  * - p < 0.05 and ** - p < 0.01 compared between control and lupus 
Table 3. Assessment of erythropoiesis at the level of early and late hematopoietic precursors 
in lupus mice 
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Changes in bone marrow smears of SLE patients with autoimmune hemolytic anemia and 
ones of lupus recipients are similar. The relative and absolute number of BFU-E in the bone 
marrow increases in lupus recipients compared with intact animals. 
The decrease of hemoglobin and hematocrit in lupus recipients is accompanied by 
reticulocytosis and hypertrophy of erythropoiesis in the bone marrow, thus it becomes 
apparent that anemia develops as a result of increased destruction of erythrocytes.  
Increasing the number of BFU-E and nucleated erythroid precursors suggests hypertrophy 
of erythron in lupus mice. Similar changes of erythron are observed in mice NZB, whose 
autoimmune hemolytic anemia is accompanied by increased numbers of early erythroid 
precursors in the bone marrow and spleen (Orlovskaja & Kozlov, 2001). 
Autoimmune hemolytic anemia is diagnosed in the presence of variable intensity of anemia 
(usually macrocytic), reticulocytosis, and a positive direct and/or indirect antiglobulin test 
after ruling out other types of hemolytic anemia. 
Coombs test (direct antiglobulin test) is used to verify the occurrence of erythrocyte-bound 
antibodies which mediate red cell destruction in anemic mice. Autoantibodies to 
erythrocytes have been determined by this test at weekly intervals, starting at week 1 and 
lasting until week 12 after the initiation of the GVHR. Coombs-positive erythrocytes begin 
to appear at early stages of reaction. It has been established that the frequency of Coombs-
positive results within 1-2 months after induction of GVHD achieves 60%. In mice with 
positive results of Coombs-test hematocrit is reduced by 26%, hemoglobin by 33%. Immune 
complex glomerulonephritis develops in 52% of mice with positive Coombs test at the early 
stages of GVHR. However a positive direct antiglobulin test alone is not sufficient to 
diagnose of autoimmune hemolytic anemia and may be positive in many patients without 
anemia or negative in some patients with one.  
It has been studied the possibility of correction of impaired erythropoiesis by hypoxia (Table 
4). Hypoxia has had favorable effect on anemia, significantly increasing hematocrit and 
hemoglobin levels and reducing the increased number of reticulocytes (Kolesnikova et al., 
2001).  
 
Parameters 
control lupus 
intact hypoxia 
without 
hypoxia 
hypoxia 
Hemoglobin, g/l 197.5  3.5 224.5  7.8 137.3  6.9** 186.0  4.6## 
Hematocrit, per cent 49.2  0.4 50.0  1.3 34.2  0.9 ** 39.5  0.9 # 
Reticulocytes, per 
mille 
10.0  1.3 - 26.2  4.7 ** 12.3  1.1# # 
(M  m,  ** - p < 0.01 compared between control and  lupus, # - p < 0.05 and ## - p < 0.01 compared 
between lupus without hypoxia and lupus with hypoxia 
Table 4. The influence of hypoxia on hemoglobin and hematocrit levels, reticulocyte number 
in lupus mice 
It is known that hypoxia stimulates the production of erythropoietin by kidney. It is used for 
treatment anemia with a decrease of erythropoiesis (Eckardt et al., 1989). There are no 
available data on the use of chronic hypoxia for treatment of moderate hemolytic anemia 
with increase of bone marrow erythropoiesis combined with immunopathology. In this 
model it has been shown some positive effect of chronic hypoxia on GVHR induced 
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immunopathology: hypoxia increases humoral immune response, abolishes anemia and 
corrects of early and late committed hemopoietic precursors number (Kolesnikova et al., 
2001). Apparently initial increase of erythropoietin synthesis leads to the growth of 
hemoglobin level in blood. When a level of hemoglobin in blood is restored, the hyperplasia 
of bone marrow hemopoietic cells stops. 
2.2.4 Macrophages 
Macrophages play a pivotal role in development of immune response and inflammatory 
reactions, acting as effectors and regulatory cells. Their participation in renal development, 
damage and repair has been well described (Williams et al., 2010). In pathogenesis of 
immune-mediated kidney injury different types of macrophages take part. There are 
resident renal macrophages (mesangial cells), macrophages differentiated from blood 
monocytes migrating in site of inflammation, and macrophages located in other organs (e.g. 
spleen and lymph nodes macrophages). 
Resident renal macrophages are supposed to play protective role in mechanism of 
glomerular damage induced by immune complexes via scavenging and preventing immune 
complexes depositions in glomeruli. This “physiologic” clearance of immune complexes is 
nonphlogistic and does not lead to increased production of inflammatory mediators 
(Duffield, 2003; Serhan & Savill, 2005; Bergtold et al., 2006; Castano et al., 2009). But if these 
mechanism is overwhelmed it results in deposit formation on glomerular basal membrane 
causing leukocytes activation, liberation of cytotoxic and chemoattracting products, local 
kidney injury and recruitment of further leukocytes (Gomez-Guerrero et al., 2004, 2005; 
Berger & Daha, 2010). These processes contribute a progressive loss of renal functions.  
Severity of clinical manifestation of kidney diseases closely correlates with intensity of 
macrophages infiltration (Van Goor et al., 1994; Duffield, 2010). Transfer of semiallogeneic 
lymphoid cells from DBA/2 mice to (C57Bl/6xDBA/2)F1 hybrids leads to rapid 
accumulation of CD11a-positive leukocytes in renal glomeruli which is maximal within 4 
weeks after GVHD induction and is synchronized with the time of proteinuria onset 
(Kootstra et al., 1998). Moreover in the murine model of proliferative glomerulonephritis 
caused by deposition of immune complexes  at the glomerular basal membrane it has been 
shown that macrophages ablation ameliorates severity of injury (Guo et al., 2009). 
Role of macrophages in kidney injury and repair can also depend on the mechanism of their 
activation. It is suggested that macrophages can polarize and differentiate into different 
subpopulations of activated cells according to a type of stimuli. In common, polarized 
macrophages can be divided into 2 basic groups: classical activated macrophages (they are 
named M1 cells, reminiscent of T-lymphocyte subsets) differentiate by Th1-associated 
cytokine IFNǄ and microbe component such as LPS and alternatively activated 
macrophages (M2) including subpopulations of M2a (activated by Th2-dependent cytokines 
IL-4 and IL-13), M2b (activated via FcR) and M2c (requiring IL-10, TGFǃ or glucocorticoids). 
These subpopulations of activated and polarized macrophages have different phenotypes 
and spectrum of secreting chemokines/cytokines (Martinez et al., 2008, 2009; Gordon & 
Martinez, 2010) and play different roles in mechanism of immunologic inflammation of the 
kidney (Williams et al., 2010). It is commonly accepted that M1 cells producing large amount 
of nitric oxide and reactive oxygen species by NO synthase and NADPH oxidase, 
respectively, mediate renal tissue damage while M2 cells producing significant amounts of 
proline and polyamines stimulate cells proliferation and sclerotic processes.  
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* - p < 0.05 compared between control and experimental group; # - p < 0.05 between experimental 
groups 
Fig. 7. Activity of NO synthase (A) and arginase (B) in recipients  
It is established that M1 and M2 cells are significantly differ from each other by the ways of 
arginine metabolism, which is a substrate of both NO synthase and arginase. M1 
macrophages are characterized by high production of NO in combination with low activity 
of arginase, while for M2 it is typical an inverse relationship, since the balance in this 
subpopulation of macrophages shifts toward the reaction catalyzed by arginase (Munder et 
al., 1998). Thus determining the ratio of NO synthase and arginase activities in the culture of 
macrophages can evaluate the M1 and M2 subpopulations balance and its changes under 
influence of various agents. 
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Study of arginine metabolism in peritoneal macrophages of recipients has been shown that 
macrophages isolated from lupus mice expose high arginase activity and macrophages 
isolated from nonlupus mice without clinical symptoms of kidney disease produce large 
amount of nitric oxide upon LPS/IFNǄ stimulation (Fig. 7). 
According their metabolic properties it has been supposed that Th1-dependent variant of 
chronic GVHD is associated with classical macrophages activation with NO synthase 
prevalence, while Th2-dependent variant of chronic GVHD is characterized by alternative 
macrophages activation with arginase domination. Since it has been researched on  
peritoneal macrophages not directly involved into renal inflammation, these differences of 
arginine metabolism have systemic nature and may characterize metabolic changes in whole 
immune system. Preferential activation of M1 or M2 cells may be one of the key points of 
chronic GVHD-induced immunopathological processes. In Th2-associated type of chronic 
GVHD there are immune complexes forming deposits in renal glomeruli and causing their 
inflammatory damage. In this case high arginase activity of M2 macrophages can promote 
via enhanced polyamine synthesis the proliferation of polyclonally activated B cells and the 
increase of autoantibody production. Moreover, the local increase of arginase activity in 
renal macrophages (mesangial cells) contributes proliferative forms of glomerulonephritis 
and amplifies collagen synthesis causing glomerular sclerosis. It have been also shown that 
lowering of local NO production in glomeruli exacerbates renal injury induced by different 
ways and enforces proteinuria via glomerular hemodynamics disturbances (Cattell, 2002; 
Waddington, 2002). Controversially, high activity of macrophagal NO synthase decreases 
proliferation of T- and B-lymphocytes and amplifies activated cells apoptosis preventing 
autoimmunity expansion (Kim et al., 1999; Hoffman et al., 2002; Koide et al., 2003).  
2.2.5 Cytokines 
The key cytokines for Th1 and Th2 subpopulations are IFNand IL-4, relatively. 
Unfortunately, its concentrations have fallen outside of the bottom value of used test 
system. The concentration of IL-10, IL-15, IL-17A has been on the verge of method 
sensitivity or lower also. Data on IL-7 is presented in chapter 2.2.1. Determination of 
cytokines content in peripheral blood has reveals the increase of IL-6 and TNF levels  in 
lupus recipients (Table 5). It has been shown that serum Il-6 and IL-10 levels increase and are 
closely associated with disease activity in SLE (Chun et al., 2007). Today it’s known the 
Janus-faced role of IL-6 as pro- and antiinflammatory cytokine. IL-6 participates in the acute 
phase response, B cell maturation and macrophage differentiation. Furthermore it has been 
shown that IL-6 can promote Th1/Th2 ratio towards Th2 inducing IL-4-dependent 
differentiation of Th2 and simultaneously inhibiting Th1 polarization through IL-4-
independent mechanism (Diehl & Rincon, 2002). Thus, the high level of IL-6 coincides with 
the increase of CD19+ B lymphocytes in spleen of lupus recipients and does not contradict to 
shifting their Th1/Th2 balance towards Th2 (Fig. 8).  TNF is also multifunctional cytokine 
and is involved in the different immune processes.  Except proinflammatory effects it is 
likewise an important factor of physiologic processes of B cells growth and activation. It has 
been shown that its level is increased in the blood and in the inflamed kidneys of systemic 
lupus erythematosus patients (Aringer & Smolen, 2003) although its role  in human SLE is 
controversial (Aringer & Smolen, 2008; Zhu et al., 2010). The high level of TNF likely 
accounts for processes of inflammation in kidney; a possible cause of its increase is 
discussed in chapter 2.2.6. 
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 IL-2 IL-6 TNFǂ 
control 
2.3 
(2.0 – 2.6) 
4.4 
(1.6 – 9.5) 
7.9 
(6.0 – 10.2) 
nonlupus
2.6 
(2.0 – 2.9) 
2.3 
(0 – 4.8) 
9,03 
(0 – 15.7) 
lupus 
2.9 
(2.3 – 3.6) 
8.9# 
(0 – 17.4) 
19.1*# 
(7.1 – 40.6) 
(M, min – max; pg/ml; * - p < 0.05 between control and experimental group; # - p < 0.05 between 
experimental groups 
Table 5. The cytokines concentration in serum of recipients 
 
 
* - p < 0.05 between control and experimental group; # - p < 0.05 between experimental groups 
Fig. 8. The content of CD19+ cells in the spleen of recipients with chronic GVHD  
2.2.6 Change of cholesterol metabolism in recipients with glomerulonephritis 
The development of lupus-like nephritis in described experimental model of chronic GVHD is 
associated with severe hyperlipidemia (Xiao et al., 2007; Perminova et al., 2009). According to 
our experimental data (Fig. 9) increase of serum cholesterol level in mice with autoimmune 
glomerulonephritis is most pronounced in the period corresponding to the formation of 
kidney damage and the appearance of proteinuria (about within 3 months after induction of 
chronic GVHD), however, and after 5 months, and even after 12 months concentration of 
cholesterol in the blood of these animals remains significantly elevated. It has been also found 
that in these mice the triglyceride level in serum is significantly increased (from 1.72 mM in 
intact control to 5.25 mM in lupus recipients; p < 0.01). At the same time nonlupus mice have 
normal cholesterol and triglyceride levels. Our results of the study blood cholesterol levels in 
the dynamics of chronic GVHD indicate that hypercholesterolemia and formation of 
autoimmune glomerulonephritis  occur simultaneously (Fig. 10). In the initial stages of 
induction of GVHD individual animals with opposite variants of the immunopathological 
process do not significantly differ from each other, and only after 8-12 weeks serum cholesterol 
level begins to increase in mice with a lupus-like nephritis. Thus, the formation of kidney 
damage and lipid metabolism disturbance in described experimental model are parallel to 
each other and appear in the same time. 
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The coincidence between kidney diseases and changes in lipid metabolism has been known 
for a long time. As stated in one of modern articles: “Historically, Virchow first suggested 
the association between lipids and renal disease in 1858 when he described successive stages 
of fatty metamorphosis and fatty detritus in the renal epithelium in Bright’s disease” (Jiang 
et al., 2005). Now the combination of different forms of nephritis and nephrotic syndrome 
with hypercholesterolemia is well known in the clinic and is described in various forms of 
experimental nephritis in animals. It has been found experimentally that kidney disease 
combines not only with changes serum lipid levels, but also with a variety of disorders of 
lipid metabolism in tissues. In clinical and experimental works it has been evidenced that 
nephrotic syndrome is accompanied by significant changes in activity of some enzymes 
involved in cholesterol metabolism (such as HMG-CoA reductase, acyl-CoA:cholesterol 
acyltransferase, lecithin-cholesterol acyltransferase and other), by decreased expression of 
LDL receptors on membranes of hepatocytes, by decline of apolipoprotein E, and by 
impaired reverse cell cholesterol transport (Subbaiah & Rodby, 1994; Deighan et al., 2000; 
Vaziri & Liang, 2002; Shearer et al., 2005; Vaziri et al., 2011). Undoubtedly, these data are 
very important for deep understanding of the pathogenesis of hypercholesterolemia in 
nephrotic syndrome, but they do not clarify the question what are mechanisms linking 
kidney disease and changes in lipid metabolism. Initial assumption that the level of serum 
lipoproteins increases compensatory in answer to decline of serum albumin concentration, 
today is rejected as not supported by clinical and experimental data. It has been found that it 
is not correlation between serum lipid profiles and serum albumin levels while the severity 
of lipid abnormalities correlates with the degree of proteinuria and hence with extent of 
kidney damage (Vaziri & Liang, 2002; Hu et al., 2009). Thus, the question of the primary 
cause of the hypercholesterolemia development in renal disease remains not completely 
resolved. 
 
 
* - p < 0.05 between control and experimental group; # - p < 0.05 between experimental groups;  
nd - data are not available 
Fig. 9. Serum cholesterol concentrations in mice with lupus-like nephritis and in nonlupus 
mice 
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Fig. 10. Development of hypercholesterolemia in individual animals in the dynamics of 
chronic GVHD 
It is generally accepted that the main pathogenetic point of such diseases is a massive 
production of specific autoantibodies and the formation of immune complexes which 
deposite in kidney tissues and serve as trigger for the chronic inflammatory process. In our 
experiments we also have found a gradual increase in the number of antibodies to DNA at 
the early stages of nephritis development (see 2.1.1). As it would be expected greater 
number of antibodies to DNA has been detected in those animals in which lupus-like 
nephritis develops. Based on this fact and on the currently available literary data, we 
assume that an accumulation of immune complexes in tissues may be act as a connecting 
link between kidney damage and hypercholesterolemia and that cell production of 
oxysterols is a key element of this association.  
In vitro experiments demonstrate (Reiss et al., 2001) that adding of immune complexes to 
macrophages and endothelial cells inhibits the activity of mitochondrial sterol 27-
hydroxylase – a key enzyme of cholesterol metabolism present in most tissues of the body 
and converting cholesterol to 27-hydroxycholesterol which is endogenous ligand for nuclear 
liver X receptors (LXRs) (Fu et al., 2001). In vivo this effect of immune complexes must be 
resulted in the decrease of 27-hydroxycholesterol concentrations in the body and therefore 
in the decline of the activation degree of LXRs. Since the LXR activation is associated with 
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the inhibition of cholesterol synthesis de novo and with the increase of the rate of  
its degradation to bile acids (Björkhem & Diczfalusy, 2002; Wang et al., 2008), reduced  
LXR activity would be reflected by accumulation of cholesterol in the tissues  
and by hypercholesterolemia. Schematic representation of these relationships is  shown in 
Figure 11. 
As of now, this assumption presents a pure speculative construction, but there are 
experimental evidences counting in favour of this hypothesis. In particular, it has long been 
known that many of the autoimmune diseases accompanied by increased formation of 
immune complexes are associated with pronounced hypercholesterolemia. A classical 
examples of such illnesses are autoimmune injuries of kidneys and systemic lupus 
erythematosus (McMahon & Hahn, 2007). According to literary data, the close relation 
between accumulation of immune complexes in tissues and hypercholesterolemia is the 
characteristic feature of the murine lupus-like syndromes developing spontaneously in 
(NZB x NZW)F1 mice, in MRL/lpr, BXSB and other relevant mouse strains (Ogura et al., 
1989; Itoh et al., 1994; Gu et al., 1999; Kono et al., 2000; Lawman et al., 2004). Similar 
association has come to light also in experimental investigations of a various immune 
complex renal injuries induced in animals by the administration of HgCl2, cationic bovine 
serum albumin and antibodies to renal proteins (Couser et al., 1978; Bagenstose et al., 1999; 
Shi et al., 2005; Wu et al., 2008).  
 
 
 
Fig. 11. A schematic representation of possible impact of immune complexes on the 
biosynthesis and catabolism of cholesterol 
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Described in this paper (see Table 5) increase of TNF in the serum of lupus mice 
emerging simultaneously with the appearance of proteinuria and hypercholesterolemia, 
also can be attributed to decreased production of 27-hydroxycholesterol since oxysterols 
(via LXR) inhibit an expression and synthesis of proinflammatory cytokines (Dushkin et 
al., 1998; Hong et al., 2011). These currently available indirect evidences are in good 
agreement with the foregoing hypothesis, however its proof requires further experimental 
investigations. 
2.2.7 Sex differences of autoimmune glomerulonephritis formation in the 
experimental model 
As it’s known there is a pronounced sexual dimorphism in the incidence of many human 
autoimmune pathologies, particularly systemic lupus erythematosus (Whitacre, 2001). It has 
been shown that the induction of chronic GVHD in the semiallogeneic system 
DBA/2(C57Bl/10xDBA/2)F1 causes the formation of autoimmune pathology only in 
female recipients for up to 6 weeks (Van Griensven et al., 1997).  
 
Parameter 
Females Males 
control lupus control lupus 
renal cortex 
Tubules 90.2 (88-91) 66.3*#(50-81) 90.8 (89-93) 88.1# (79-96) 
Glomeruli 3.4 (3-5) 1.5* (1-3) 3.9 (3-5) 2.0* (1-4) 
Blood vessels 5.9 (5-7) 2.1*# (1-3) 5.3 (3-7) 3.4*# (2-5) 
Leukocyte 
infiltration 
0.2 (0-2) 13.2*# (5-19) 0 0# 
Cylinders 0 7.4* (2-15) 0 3.6* (0-9) 
Cysts and cavities 
with liquid 
0 9.5* (3-21) 0 2.9* (0-7) 
renal medulla 
Tubules and ducts 95.8 (95-96) 94.9 (93-97) 97.5 (97-99) 97.3 (95-99) 
Blood vessels 4.0 (3-5) 1.3*# (1-2) 2.5 (1-4) 2.2# (1-4) 
Cylinders 0 3.8*# (3-5) 0 0.5*# (0-1) 
(M, (min-max);  * - p < 0.05 between control and experimental group; # - p < 0.05 between experimental 
groups 
Table 6. The relative area of the structures on the cut renal cortex and renal medulla  
(% of section area)  
In case of DBA/2(C57BL/6xDBA/2)F1 model it has been observed that induction of 
GVHD using female donor and host mice causes more severe glomerulonephritis than one 
using male donor and host. This is not due to differences in splenic homing, alloreactive 
precursor frequency, initial proliferation rates, or apoptotic rates but rather to sustained 
high proliferative activity at early stage of GVHR. Crossover studies (female donor and 
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male host; male donor and female host) has revealed that this effect is depended on the host 
sex (Lang et al., 2003). In our experiments chronic GVHD induced by transfer of female 
donor cells leads to the development of glomerulonephritis in recipients of both sexes by the 
end of 3 months. Kidney pathological picture in male recipients is characterized by less 
pronounced glomerular and tubular lesions, the absence of leukocyte infiltration and vessel 
walls damage compared with females littermates (Table 6) (Kudaeva et al., 2009). 
Determination of the testosterone level in the peripheral blood of female lupus mice has 
shown an increase of its concentration (6.1 nM compared with 4.8 nM in intact females of 
the same age, p < 0.05). It may be explained by the compensatory response to kidney 
damage, taking into account renotropic effect of testosterone. However testosterone level in 
female nonlupus recipients is also increased (7.7 nM, p < 0.05). 
Currently great attention is paid to sex hormones as regulators of immune responses. 
Higher incidence of autoimmune pathologies in women, its changing during pregnancy, sex 
differences of immune response, the influence of sex hormones on Th1/Th2 balance identify 
the role of sex hormones, mainly estrogen, progesterone and testosterone, as mediators of 
sexual dimorphism in the immune system (Erlandsson et al., 2003; Soldan et al., 2003; 
Cutolo et al., 2004; Matejuk et al., 2004). Less pronounced renal damage in males and 
increase of testosterone level in female recipients suggest testosterone as a factor of 
regulation, suppressed autoimmune processes during chronic GVHD. 
2.3 Modulation by Th1/Th2 balance shifting 
Currently, there is evidence of the possibility of Th1/Th2 balance changing through a 
variety of factors under the immunopathological situations, in particular, under the 
development of allergic diseases (Kato et al., 1999; Raz & Spiegelberg, 1999; Tipping & 
Kitching, 2005). Since a formation of autoimmune glomerulonephritis induced by chronic 
GVHR is a Th2-dependent process whereas a development of chronic GVHR without a 
kidney damage is a Th1-dependent one it has been studied the possibility to change the 
direction of reaction by agents shifting Th1/Th2 ratio towards Th1 or Th2. Drugs have been 
administered during the induction of the reaction (the first and second week of GVHR). 
Results have assessed by the change in the proportion of lupus recipients at the end of the 
experiment (within 3 months after the transfer semiallogeneic cells). 
2.3.1 Shifting Th1/Th2 ratio towards Th1 
DNA with immunostimulating properties (pUC19 plasmid DNA) and hormone 
dehydroepiandrosterone (in its transport form – dehydroepiandrosterone sulfate) are used 
as agents stimulating Th1 subpopulation. 
It has been shown that injection of bacterial DNA containing nonmethylated CpG-plots 
stimulates production of Th1 cells activating cytokines: TNF, IL-1, IL-12, IFN(Klinman et 
al., 1996; Carson & Raz, 1997; Krieg, 1999). pUC19 plasmid DNA is injected intravenously 
twice in dose 5 mg/kg. Calf thymus DNA in the same dose and scheme is used as a control. 
Dehydroepiandrosterone sulfate is taken as Th1 activator (Stam et al., 1993; Rook et al., 1994; 
Sudo et al., 2001). Dehydroepiandrosterone sulfate restores production of Th1-dependent 
cytokines by old female mice (Araghi-Niknam et al., 1997). Dehydroepiandrosterone sulfate 
(Aldrich) has been injected subcutaneously 4 times in dose 37.5 mg/kg. 
Results are shown in Figure 12. Both pUC19 plasmid DNA and dehydroepiandrosterone 
sulfate decrease the proportion of lupus recipients directing the reaction to Th1-dependent 
nonlupus variant (Vlasov et al., 2002; Tkachev et al., 2009). 
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* - p < 0.05 compared to GVHD; # - p < 0.05 compared to GVHD+dsDNA) 
Fig. 12. Frequency of lupus mice among the recipients upon the effect of pUC19 plasmid 
DNA (A) and DHEA-S (B)  
2.3.2 Shifting Th1/Th2 ratio towards Th2 
It has been studied the possibility of modifying the course of reaction towards Th2-
dependent processes also (Kudaeva et al., 2005b). Compounds with different mechanisms of 
action shifting the Th1/Th2 ratio towards Th2 cells have been used as immunomodulators: 
muramyl dipeptide, bisphenol A, and pentoxifylline. Muramyl dipeptide, a bacterial cell 
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wall derivative characterized by adjuvant effect, causes polyclonal activation of B-cells, and 
potentiates the stimulatory effect of IL-4 on activated B-lymphocytes (Souvannavong et al., 
1990). Muramyl dipeptide (ICN) has been injected intraperitoneally in a dose of 1.0 mg/kg 
twice ten days apart. Bisphenol A widely used in the industrial manufacture of plastics 
binds to estrogen receptors despite structural differences from the hormone. It decreases 
production of IFNǄ and synthesis of IgG2a (Sawai et al., 2003). Bisphenol A (ICN) has been 
given intraperitoneally in a daily dose of 2.5 μg/kg for 2 weeks. Pentoxifylline (a drug 
improving microcirculation and blood rheology) inhibits production of proinflammatory 
cytokines including IFNǄ and suppresses the development of Th1-dependent experimental 
allergic encephalomyelitis in mice (Okuda & Sakoda, 1996). Pentoxifylline (Aventis Pharma 
Ltd.) has been given per os in a daily dose of 50 mg/kg for 1 week.  
All these drugs cause an increased protein concentration in the urine of lupus recipients (Fig. 
13) that strictly correlates with the severity of kidney damage (Kolesnikova et al., 1991). 
Moreover these drugs increase the incidence of lupus-like glomerulonephritis among 
recipients (Kudaeva et al., 2005b). Hence they deteriorate a course of a disease. 
So, in this experimental model the change of the Th1/Th2 balance by introduction of 
immunomodulating drugs causes the amelioration or the progression of kidney damage. 
 
 
* - p < 0.05 compared with control; # - p < 0.05 compared with GVHD; BPA - bisphenol A;  
MDP – muramyl dipeptide; PTX - pentoxifylline 
Fig. 13. Protein concentration in urine of recipients  
2.4 Correction of glomerulonephritis  
In addition to studying the pathogenesis of autoimmune glomerulonephritis, it has been 
also investigated the possibility of correcting fully developed disease in this experimental 
model (Kudaeva et al., 2010a). 
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Lupus recipients have been lethally irradiated and then injected of bone marrow cells from 
intact syngeneic donors into a vein. Monitoring of follow-up processes have been included 
regular determination of the protein concentration in the urine. It has been found that such 
treatment of lupus recipients leads to a gradual decrease in the protein concentration in 
urine, the level of which is not differ from control values at the end of the experiment (Fig. 
14). This result can be regarded as evidence of the positive effect of the therapy. 
2.4.1 Immune parameters 
At the end of the experiment it has been studied kidney morphology and measured body, 
thymus and spleen weight, cell number and the levels of total IgG and IgG-antibodies to 
DNA in peripheral blood. 
Mice with chronic GVHD are characterized by severe splenomegaly and polyclonal 
activation of B cells, leading to high levels of IgG in peripheral blood and the appearance of 
antibodies to components of its own tissues (Via & Shearer, 1988; Morris et al., 1990). After 
treatment spleen cells number and the concentration of IgG in peripheral blood of lupus 
recipients are not differ from the appropriate values of control (intact animals lethally 
irradiated and then injected of bone marrow cells from syngeneic donors). Correction of 
clinical manifestations of glomerulonephritis has been also accompanied by the 
disappearance of IgG antibodies to DNA from peripheral blood (Fig. 15). 
It has not been significant difference in thymus weight between lupus mice before the 
treatment and control intact animals of the same sex and age. After the treatment its value in 
lupus recipients has diminished but has been not differ from irradiated and restored control. 
It may be due to slowing thymus recovery in mice of such age. 
2.4.2 Kidney morphology  
The results of morphological study of kidneys are presented in Tables 7-9. Formation of 
glomerulonephritis in lupus mice has been accompanied by development of inflammatory 
reaction with leukocyte infiltration, microcirculation change (an impairment of the 
permeability, a blockade of the venous capillaries) and lymphostasis in the renal 
parenchyma. All the pathological changes of the kidneys in lupus recipients indicate the 
active acute glomerulonephritis lasting for a long time (a different cell composition of 
leukocyte infiltrates, a large number of cylinders in the tubules and destructive changes in 
the glomeruli). After lethal irradiation and injection of syngeneic bone marrow cells it has 
been observed a fall in edema, in a severity of inflammation, in a leukocyte infiltration. In 
addition, a sharp decrease in the number of plasma cells in the leukocyte infiltrates, a large 
number of those present in lupus mice has been observed after therapy. At the end of the 
experiment number of plasma cells  has been not differ from intact control values. 
Individual recipients have had various intensity of these changes. It has been no reverse 
development of pathological changes of glomeruli except of the reduction of leukocyte 
infiltration and edema. Restoration of structures of impaired glomeruli has been no 
observed. The latter is in agreement with the observation that regeneration of mammals 
kidney structure is demonstrated for renal tubular epithelium only (Hishikawa & Fujita, 
2006; Poulsom et al., 2006; Bi et al., 2007). Another results have been obtained in a model of 
autosomally recessive Alport syndrome. Mice that lack the 3 chain of collagen IV fail to 
synthesize normal glomerular basement membrane and develop progressive glomerular 
damage leading to renal failure; bone marrow transplantation can rectify this podocyte 
www.intechopen.com
 
An Update on Glomerulopathies – Etiology and Pathogenesis 
 
72
defect but the mechanisms underlying repopulation of glomerular podocytes by bone 
marrow-derived cells are not yet clear (Prodromidi et al., 2006). 
 
 
* - p < 0.05 between control and experimental group, # - p < 0.05 between experimental groups 
Fig. 14. Protein content in urine of recipients 
 
 
* - p < 0.05 between control and experimental group; # - p < 0.05 between experimental groups 
Fig. 15. The level of antibodies to dsDNA in peripheral blood of lupus recipients 
www.intechopen.com
The Experimental Model of the Autoimmune  
Glomerulonephritis Induced by the Chronic Graft versus Host Reaction 
 
73 
Parameter 
groups of animals * 
 
1 2 3 4 
Tubules 
90.23,4** 
(88-92) 
88.94 
(82-94) 
66.31,4 
(50-81) 
78.51,2,3 
(61-89) 
Glomeruli 
3.43,4 
(3-5) 
3.74 
(3-5) 
1.51 
(1-3) 
1.41,2 
(0-3) 
Blood vessels 
5.92,3,4 
(5-7) 
3.71,4 
(3-5) 
2.11,4 
(1-3) 
4.91,2,3 
(3-7) 
Connective tissue 0 0 0 0 
Leukocyte infiltration 
0.22,3,4 
(0-2) 
1.91,4 
(0-5) 
13.21 
(5-21) 
9.81, 2 
(6-14) 
Cylinders 
03,4 
 
04 
 
7.41,4 
(3-15) 
1.11,2,3 
(0-3) 
Cysts and cavities with 
liquid 
02,3,4 
 
1.81 
(0-5) 
9.51,4 
(3-21) 
3.61,3 
(0-18) 
Hemorrhage 
0.3 
(0-10) 
0 
 
0 
 
0.7 
(0-5) 
M, (min-max);  * the groups of animals: 1 – control, intact mouse; 2 – the control, irradiation and transfer 
of bone marrow cells;  3 – the mouse with chronic GVHD, lupus; 4 – the mouse with chronic GVHD, 
lupus, irradiation and transfer of bone marrow cells; * 1, 2, 3, 4– the groups that have significant differences 
among themselves 
Table 7. The relative area of the structures on the cut renal cortex (% of section area) 
 
Parameter 
groups of animals* 
1 2 3 4 
Tubules and ducts 
95.82,4** 
(95-97) 
96.61 
(96-97) 
94.94 
(93-97) 
97.11,3 
(96-98) 
Blood vessels 
4.02,3,4 
(3-4) 
3.41,4 
(3-4) 
1.31,4 
(1-2) 
2.71,2,3 
(2-4) 
Connective tissue 0 0 0 0 
Leukocyte infiltration 0 0 0 0 
Cylinders 03 0 
3.81, 4 
(2-5) 
0.23 
(0-1) 
Cysts and cavities with 
liquid 
0 0 0 0 
Hemorrhage 0 0 0 0 
M, (min-max); * the groups of animals as  in table 7; * 1, 2, 3, 4– the groups that have significant differences 
among themselves 
Table 8. The relative area of the structures on the cut renal medulla (% of section area)  
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groups of animals * 
 
1 2 
3 
 
4 
Number (N) of renal 
infiltrates (%) 
10 60 100 100 
 
 
Area cut 
infiltration 
 
AA**** 
 
0.23,4** 
(0-2) 
1.94 
(0-5) 
13.21 
(6-18) 
9.81, 2 
(6-14) 
A***** 75002,3,4 
135001 
(6875-26250) 
376251,4 
(26875-51875) 
193751,3 
(6250-
42500) 
Numerical density 
leukocytes (NA***) 
19.0 
 
28.0 
(16-37) 
28.2 
(19-40) 
30.4 
(21-37) 
Neutrophils 
% 0 
0.84 
(0-20) 
2.3 
(1-3) 
2.12 
(0-5) 
NA 0 
0.2394 
(0-0.68) 
0.66 
(0.24-1.14) 
0.6112 
(0-1.11) 
Monocytes 
% 
 
3 
 
4.4 
(2-7) 
4.1 
(3-5) 
3.1 
(1-4) 
 
NA 
 
0.57 
1.18 
(0.57-1.92) 
1.17 
(0.57-1.9) 
0.931 
(0.63-1.36) 
Macrophages 
% 
 
48.0 
 
22.4 
(9-41) 
24.8 
(15-35) 
23.7 
(9-42) 
NA 
 
9.12 
5.65 
(2.43-7.68) 
7.03 
(3.15-13.3) 
7.39 
(2.1-14.28) 
Fibroblasts and 
fibrocytes 
% 
 
18 
 
8 
(0-34) 
1.24 
(0-3) 
9.63 
(0-34) 
NA 
 
3.42 
2.51 
(0-10.2) 
0.3064 
(0-0.96) 
3.243 
(0-12.58) 
Plasma cells 
% 
 
0 
10 
(0-42) 
17.74 
(8-33) 
2.13 
(0-6) 
NA 
 
0 
2.63 
(0-8.96) 
5.354 
(1.9-13.2) 
0.663 
(0-1.92) 
M, (min-max); * the groups of animals as in table 7; ** 1, 2, 3, 4– the groups that have significant differences 
among themselves; 
***NA - numerical density of cells per 103 m2; 
****AA - relative area of infiltration at the cut renal cortex (% of section area); 
***** А - area of leukocyte infiltration (m2).  
Table 9. Characteristics of leukocyte infiltration in renal cortex  
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The data allow to conclude that induced by chronic GVHD immune complex 
glomerulonephritis of autoimmune genesis is maintained in the recipients by prolonged 
activity of immune cells. This inference is supported by data that the alloreactive donor T 
cells maintaining hyperplasia of host B lymphocytes with production of lupus-like 
antibodies persist in GVHD F1 mice for a long time after the induction of chronic GVHR 
(Rozendaal et al., 1990). Lethal irradiation interrupts the autoimmune process confirmed by 
disappearance of antibodies to DNA in peripheral blood and plasma cells in the kidney 
leukocyte infiltrates and consequently reduces the severity of kidney damage and leads to 
disappearance of clinical manifestations of glomerulonephritis – proteinuria. 
3. Conclusion  
Epigenetic mechanisms are long-term but reversible changes of gene activity not connected 
with DNA nucleotide sequence. Now it isn’t doubted that epigenetic mechanisms play the 
important role in determination of individual immune reactions. A purposeful integration 
of immune reactions with adaptive processes of whole organism is achieved by epigenetic 
regulation (Vercelli, 2004; Reiner, 2005; Wilson et al., 2005). Consequently, the character of 
immune reactions and their final effects are not defined by the animal genotype and 
parameters of antigenic action on an organism only but are determined by its «epigenetic 
component» taking during ontogenesis also. In such a manner individual living conditions 
form the current stable state of immune system modifying immune characteristics of 
individual predetermined by genotype. Accompanied by genetic heterogeneity of natural 
populations these variations of immune parameters, based on epigenetic mechanisms, 
provide the observed diversity of individual responses to antigenic stimuli and form the 
perceptivity to infections and different diseases in developing of which functional activity of 
immune cells plays an appreciable role. 
Th1 and Th2 activation has been shown to be affected in antagonist manner by numerous 
regulatory factors including hormones, mediators, and other biologically active substances 
(Rook et al., 1994; Piccini et al., 1995; Elenkov et al., 2000; Elenkov, 2004). The dissimilar level 
of biologically active molecules in recipient’s organism may cause predominantly 
stimulation of Th1- or Th2-cells and as a consequence directs the GVHD development for 
Th1- or Th2-dependent ways and initiates predominantly the development of nonlupus or 
lupus variants respectively. 
Experimental animals are a genetic homogenous group; transplanted cells have been 
identical for all recipients; the animal keeping conditions and transplanting procedure have 
been constant and the same for all mice in our work. Nonetheless there are two different 
variants of GVHD in our experiments. It is undoubtedly that even when experimental 
animals have identical genotype, there is always the dispersion of results that is usually 
considered as methodic imperfection. It is quite possible that such dispersion is rather an 
adequate reflection of the really existing situation: in spite of initial genetic identity animals 
are taking some stable distinctive properties in response to environmental influences by 
epigenetic mechanisms during ontogenesis (Jaenisch & Bird, 2003; Anway et al., 2005; 
Horsthemke & Ludwig, 2005; Reiner, 2005; Wong et al., 2005).  
Thus, in spite of the genetic, sexual and age uniformity of recipients, the same living 
conditions and the standard transfer procedure, the trend of the chronic GVH disease can 
proceed in the classical Th2- or early not described Th1-dependent pathways in the 
DBA/2(C57Bl/6xDBA/2)F1 system that eventually causes the development of two 
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variants of immunopathology, only one of them results in the autoimmune disorder – 
lupus-like immune complex glomerulonephritis. This  model of the immunopathology 
permits the study of lupus-like nephritis pathogenesis. Furthermore it allows to use of 
GVHD  in the DBA/2(C57Bl/6xDBA/2)F1 system for devise practicable drugs and 
regimens of treatment during all stages of disease.  
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